Ranbaxy's Provigil gets tentative FDA approval
Facebook Twitter google+ RSS Feed

Ranbaxy's Provigil gets tentative FDA approval

By siliconindia staff writer   |   Friday, 20 February 2004, 08:00 Hrs
Printer Print Email Email
MUMBAI: Ranbaxy Laboratories has got tentative approval for Modafinil tablets, a generic form of nacrolepsy drug Provigil, the US Food and Drug Administration (FDA) said late on Thursday.

Provigil, the flagship drug of Cephalon Inc, is prescribed for a rare disorder marked by uncontrollable sleep during normal waking hours.

No other details were immediately available.




Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset
SPOTLIGHT